Abstract
Twenty-seven 2-acetylpyridine thiosemicarbazones and analogs were tested for antitrypanosomal activity against Trypanosoma rhodesiense using a semiautomated in vitro assay system. Activity was determined by relative inhibition of uptake of two radiolabeled macromolecular precursors, [methyl-3H]thymidine and L-[U-14C]leucine, as compared to untreated controls. It was observed that the nitrogen atom of the pyridyl moiety of the 2-acetylpyridine thiosemicarbazones was essential for antitrypanosomal activity. The 2-acetylpyridine thiosemicarbazones generally inhibited the uptake of L-[U-14C]leucine to a greater extent than they inhibited [methyl-3H]thymidine uptake. Twenty-four of the 27 compounds tested exhibited activity comparable to that found for the antitrypanosomal agent ethidium bromide.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Agrawal K. C., Booth B. A., DeNuzzo S. M., Sartorelli A. C. Potential antitumor agents. 12. 2-Formyl-4-aminophenylpyridine thiosemicarbazones. J Med Chem. 1975 Apr;18(4):368–371. doi: 10.1021/jm00238a009. [DOI] [PubMed] [Google Scholar]
- Dobek A. S., Klayman D. L., Dickson E. T., Jr, Scovill J. P., Tramont E. C. Inhibition of clinically significant bacterial organisms in vitro by 2-acetylpyridine thiosemicarbazones. Antimicrob Agents Chemother. 1980 Jul;18(1):27–36. doi: 10.1128/aac.18.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
- EASTERBROOK K. B. Interference with the maturation of vaccinia virus by isatin beta-thiosemicarbazone. Virology. 1962 Jun;17:245–251. doi: 10.1016/0042-6822(62)90114-9. [DOI] [PubMed] [Google Scholar]
- French F. A., Blanz E. J., Jr, DoAmaral J. R., French D. A. Carcinostatic activity of thiosemicarbazones of formyl heteroaromatic compounds. VI. 1-Formylisoquinoline derivatives bearing additional ring substituents, with notes on mechanism of action. J Med Chem. 1970 Nov;13(6):1117–1124. doi: 10.1021/jm00300a024. [DOI] [PubMed] [Google Scholar]
- Giner-Sorolla A., McCravey M., Longley-Cook J., Burchenal J. H. Heterocyclic thiosemicarbazones and related derivatives. Synthesis and screening data. J Med Chem. 1973 Sep;16(9):984–988. doi: 10.1021/jm00267a006. [DOI] [PubMed] [Google Scholar]
- Klayman D. L., Bartosevich J. F., Griffin T. S., Mason C. J., Scovill J. P. 2-Acetylpyridine thiosemicarbazones. 1. A new class of potential antimalarial agents. J Med Chem. 1979 Jul;22(7):855–862. doi: 10.1021/jm00193a020. [DOI] [PubMed] [Google Scholar]
- Klaymann D. L., Scovill J. P., Bartosevich J. F., Mason C. J. 2-Acetylpyridine thiosemicarbazones. 2. N4,N4-Disubstituted derivatives as potential antimalarial agents. J Med Chem. 1979 Nov;22(11):1367–1373. doi: 10.1021/jm00197a017. [DOI] [PubMed] [Google Scholar]
- Lanham S. M., Godfrey D. G. Isolation of salivarian trypanosomes from man and other mammals using DEAE-cellulose. Exp Parasitol. 1970 Dec;28(3):521–534. doi: 10.1016/0014-4894(70)90120-7. [DOI] [PubMed] [Google Scholar]
- Macadam R. F., Williamson J. Drug effects on the fine structure of Trypanosoma rhodesiense: diamidines. Trans R Soc Trop Med Hyg. 1972;66(6):897–904. doi: 10.1016/0035-9203(72)90125-3. [DOI] [PubMed] [Google Scholar]
- Protivinsky R. Chemotherapeutics with tuberculostatic action. Antibiot Chemother (1971) 1971;17:101–121. doi: 10.1159/000392367. [DOI] [PubMed] [Google Scholar]
- Rane L., Rane D. S., Kinnamon K. E. Screening large numbers of compounds in a model based on mortality of Trypanosoma rhodesiense infected mice. Am J Trop Med Hyg. 1976 May;25(3):395–400. doi: 10.4269/ajtmh.1976.25.395. [DOI] [PubMed] [Google Scholar]
- Weinstein L., Chang T. W. The chemotherapy of viral infections. N Engl J Med. 1973 Oct 4;289(14):725–730. doi: 10.1056/NEJM197310042891405. [DOI] [PubMed] [Google Scholar]
- Wilson H. R., Revankar G. R., Tolman R. L. In vitro and in vivo activity of certain thiosemicarbazones against Trypanosoma cruzi. J Med Chem. 1974 Jul;17(7):760–761. doi: 10.1021/jm00253a025. [DOI] [PubMed] [Google Scholar]